Free Trial

Regentis Biomaterials (RGNT) Institutional Ownership

Regentis Biomaterials logo
$1.85 -0.13 (-6.57%)
As of 04:10 PM Eastern

Institutional Ownership Changes (13F Filings) for Regentis Biomaterials (NYSEAMERICAN:RGNT)

Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$918K
Number of
Institutional Sellers
(last 12 months)
0
Get RGNT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Regentis Biomaterials stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Regentis Biomaterials Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/30/2026 AIGH Capital Management LLC300,000$916K0.1%N/A5.792%


RGNT Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Regentis Biomaterials shares: AIGH Capital Management LLC ($916K).Learn more on Regentis Biomaterials' institutional investors.

The following institutional investors have purchased Regentis Biomaterials' stock in the last 24 months: AIGH Capital Management LLC ($300K).

Institutional investors have bought a total of 300,000 shares in the last 24 months. This purchase volume represents approximately $918K in transactions.



This page (NYSEAMERICAN:RGNT) was last updated on 5/29/2026 by MarketBeat.com Staff.
From Our Partners